Hancock Whitney’s Immunomedics Inc IMMU Stock Holding History

Hancock Whitney’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-26,400	Closed	-$233K	–	620
2017 Q2	$233K	Hold	26,400	–	–	0.01%	481
2017 Q1	$171K	Hold	26,400	–	–	0.01%	534
2016 Q4	$97K	Hold	26,400	–	–	﹤0.01%	545
2016 Q3	$86K	Hold	26,400	–	–	﹤0.01%	521
2016 Q2	$61K	Hold	26,400	–	–	﹤0.01%	565
2016 Q1	$66	Hold	26,400	–	–	﹤0.01%	511
2015 Q4	$81K	Hold	26,400	–	–	﹤0.01%	519
2015 Q3	$45K	Hold	26,400	–	–	﹤0.01%	511
2015 Q2	$101K	Hold	26,400	–	–	﹤0.01%	487
2015 Q1	$101K	Hold	26,400	–	–	﹤0.01%	487
2014 Q4	$127K	Hold	26,400	–	–	﹤0.01%	491
2014 Q3	$98K	Hold	26,400	–	–	﹤0.01%	487
2014 Q2	$96K	Hold	26,400	–	–	﹤0.01%	488
2014 Q1	$111K	Hold	26,400	–	–	﹤0.01%	478
2013 Q4	$121K	Hold	26,400	–	–	0.01%	502
2013 Q3	$164K	Hold	26,400	–	–	0.01%	475
2013 Q2	$144K	Buy	+26,400	New	+$86.7K	0.01%	484

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Hancock Whitney's IMMU Position: Q3 2017 in Review

Hancock Whitney sold out of Immunomedics Inc (IMMU) in Q3 2017, closing a stake of 26,400 shares — an estimated $233K sold.

Hancock Whitney first reported a position in IMMU in Q2 2013 and held it in 17 quarters. The position peaked at $233K in Q2 2017. 150 funds tracked by Wall St. Rank hold IMMU as of Q3 2017.

Hancock Whitney reported no remaining Immunomedics Inc position as of Q3 2017 after selling out during the quarter.
Hancock Whitney sold 26,400 Immunomedics Inc shares in Q3 2017, an estimated $233K.
Hancock Whitney first reported a position in Immunomedics Inc in Q2 2013 and held it in 17 quarters.
Hancock Whitney's Immunomedics Inc position peaked at $233K in Q2 2017.
150 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2017.

Based on Hancock Whitney's 13F filing for Q3 2017, filed 14 Nov 2017.